α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion

Cancer Letters

Volumn 347, Issue 1, 2014, Pages 129-138

  Lei, Jianjun ^a   Huo, Xiongwei ^a   Duan, Wanxing ^a   Xu, Qinhong ^a   Li, Rong ^a   Ma, Jiguang ^a   Li, Xuqi ^a   Han, Liang ^a   Li, Wei ^a   Sun, Hao ^a   Wu, Erxi ^b   Ma, Qingyong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Hypoxia; Pancreatic cancer; PSC; ROS; Mangostin

Indexed keywords

ALPHA MANGOSTIN; ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ACTIVATION; CELL HYPOXIA; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INHIBITION KINETICS; OXIDATIVE STRESS; PANCREAS CANCER; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; TUMOR INVASION; UPREGULATION;

HYPOXIA; PANCREATIC CANCER; PSC; ROS; Α-MANGOSTIN;

CELL HYPOXIA; CELL LINE, TUMOR; CELLS, CULTURED; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; XANTHONES;

EID: 84897081164     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.02.003     Document Type: Article

References (51)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
2. Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20:1218-1249.
3. Clark C.E., Hingorani S.R., Mick R., Combs C., Tuveson D.A., Vonderheide R.H. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 2007, 67:9518-9527.
4. Yen T.W., Aardal N.P., Bronner M.P., Thorning D.R., Savard C.E., Lee S.P., Bell R.H. Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 2002, 131:129-134.
5. Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A., Ji B., Evans D.B., Logsdon C.D. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008, 68:918-926.
6. Neesse A., Michl P., Frese K.K., Feig C., Cook N., Jacobetz M.A., Lolkema M.P., Buchholz M., Olive K.P., Gress T.M., Tuveson D.A. Stromal biology and therapy in pancreatic cancer. Gut 2011, 60:861-868.
7. K.P. Olive, M.A. Jacobetz, C.J. Davidson, A. Gopinathan, D. McIntyre, D. Honess, B. Madhu, M.A. Goldgraben, M.E. Caldwell, D. Allard, K.K. Frese, G. Denicola, C. Feig, C. Combs, S.P. Winter, H. Ireland-Zecchini, S. Reichelt, W.J. Howat, A. Chang, M. Dhara, L. Wang, F. Ruckert, R. Grutzmann, C. Pilarsky, K. Izeradjene, S.R. Hingorani, P. Huang, S.E. Davies, W. Plunkett, M. Egorin, R.H. Hruban, N. Whitebread, K. McGovern, J. Adams, C. Iacobuzio-Donahue, J. Griffiths, D.A. Tuveson, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science (New York, N.Y.). 324, 2009, pp. 1457-1461.
8. Provenzano P.P., Cuevas C., Chang A.E., Goel V.K., Von Hoff D.D., Hingorani S.R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012, 21:418-429.
9. Jacobetz M.A., Chan D.S., Neesse A., Bapiro T.E., Cook N., Frese K.K., Feig C., Nakagawa T., Caldwell M.E., Zecchini H.I., Lolkema M.P., Jiang P., Kultti A., Thompson C.B., Maneval D.C., Jodrell D.I., Frost G.I., Shepard H.M., Skepper J.N., Tuveson D.A. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 2013, 62:112-120.
10. Apte M.V., Park S., Phillips P.A., Santucci N., Goldstein D., Kumar R.K., Ramm G.A., Buchler M., Friess H., McCarroll J.A., Keogh G., Merrett N., Pirola R., Wilson J.S. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004, 29:179-187.
11. Xu Z., Vonlaufen A., Phillips P.A., Fiala-Beer E., Zhang X., Yang L., Biankin A.V., Goldstein D., Pirola R.C., Wilson J.S., Apte M.V. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am. J. Pathol. 2010, 177:2585-2596.
12. Vonlaufen A., Joshi S., Qu C., Phillips P.A., Xu Z., Parker N.R., Toi C.S., Pirola R.C., Wilson J.S., Goldstein D., Apte M.V. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008, 68:2085-2093.
13. Radisky D.C., Kenny P.A., Bissell M.J. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT. J. Cell. Biochem. 2007, 101:830-839.
14. Radisky D.C., Przybylo J.A. Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung. Proc. Am. Thoracic Soc. 2008, 5:316-322.
15. Giannoni E., Bianchini F., Calorini L., Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid. Redox Signal. 2011, 14:2361-2371.
16. Avni R., Cohen B., Neeman M. Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed. 2011, 24:569-581.
17. Comito G., Giannoni E., Di G.P., Segura C.P., Gerlini G., Chiarugi P. Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett. 2012, 324:31-41.
18. Taddei M.L., Giannoni E., Raugei G., Scacco S., Sardanelli A.M., Papa S., Chiarugi P. Mitochondrial oxidative stress due to complex I dysfunction promotes fibroblast activation and melanoma cell invasiveness. J. Signal Transduct. 2012, 2012:684592.
19. Lei J., Ma J., Ma Q., Li X., Liu H., Xu Q., Duan W., Sun Q., Xu J., Wu Z., Wu E. Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Mol. Cancer. 2013, 12:66.
20. Pedraza-Chaverri J., Cardenas-Rodriguez N., Orozco-Ibarra M., Perez-Rojas J.M. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol. 2008, 46:3227-3239.
21. Obolskiy D., Pischel I., Siriwatanametanon N., Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res. 2009, 23:1047-1065.
22. Jung H.A., Su B.N., Keller W.J., Mehta R.G., Kinghorn A.D. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J. Agric. Food Chem. 2006, 54:2077-2082.
23. Gao Z., Wang X., Wu K., Zhao Y., Hu G. Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 axis. Pancreatology 2010, 10:186-193.
24. Bachem M.G., Schneider E., Gross H., Weidenbach H., Schmid R.M., Menke A., Siech M., Beger H., Grunert A., Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
25. Chiarugi P., Pani G., Giannoni E., Taddei L., Colavitti R., Raugei G., Symons M., Borrello S., Galeotti T., Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 2003, 161:933-944.
26. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
27. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Signal. 2012, 16:1248-1263.
28. Cat B., Stuhlmann D., Steinbrenner H., Alili L., Holtkotter O., Sies H., Brenneisen P. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J. Cell. Sci. 2006, 119:2727-2738.
29. Cronin P.A., Wang J.H., Redmond H.P. Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer. 2010, 10:225.
30. Toullec A., Gerald D., Despouy G., Bourachot B., Cardon M., Lefort S., Richardson M., Rigaill G., Parrini M.C., Lucchesi C., Bellanger D., Stern M.H., Dubois T., Sastre-Garau X., Delattre O., Vincent-Salomon A., Mechta-Grigoriou F. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol. Med. 2010, 2:211-230.
31. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., Nakada K., Honma Y., Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science (New York, NY) 2008, 320:661-664.
32. Masamune A., Watanabe T., Kikuta K., Shimosegawa T. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 2009, 7:S48-54.
33. Duner S., Lopatko L.J., Ansari D., Gundewar C., Andersson R. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology 2010, 10:673-681.
34. Giannoni E., Bianchini F., Masieri L., Serni S., Torre E., Calorini L., Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 2010, 70:6945-6956.
35. Cirri P., Chiarugi P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 2012, 31:195-208.
36. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer. 2009, 9:239-252.
37. Blick T., Hugo H., Widodo E., Waltham M., Pinto C., Mani S.A., Weinberg R.A., Neve R.M., Lenburg M.E., Thompson E.W. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J. Mammary Gland Biol. Neoplasia. 2010, 15:235-252.
38. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
39. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer. 2008, 8:755-768.
40. Giaccia A.J., Schipani E. Role of carcinoma-associated fibroblasts and hypoxia in tumor progression. Curr. Top. Microbiol. Immunol. 2010, 345:31-45.
41. Melillo G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev. 2007, 26:341-352.
42. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008, 15:660-666.
43. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 2005, 280:41928-41939.
44. Semenza G.L. Oxygen homeostasis. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2:336-361.
45. Gao P., Zhang H., Dinavahi R., Li F., Xiang Y., Raman V., Bhujwalla Z.M., Felsher D.W., Cheng L., Pevsner J., Lee L.A., Semenza G.L., Dang C.V. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 2007, 12:230-238.
46. Comito G., Calvani M., Giannoni E., Bianchini F., Calorini L., Torre E., Migliore C., Giordano S., Chiarugi P. HIF-1alpha stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radical Biol. Med. 2011, 51:893-904.
47. Youn S.W., Lee S.W., Lee J., Jeong H.K., Suh J.W., Yoon C.H., Kang H.J., Kim H.Z., Koh G.Y., Oh B.H., Park Y.B., Kim H.S. COMP-Ang1 stimulates HIF-1alpha-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 2011, 117:4376-4386.
48. Li X., Ma Q., Xu Q., Liu H., Lei J., Duan W., Bhat K., Wang F., Wu E., Wang Z. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett. 2012, 322:169-176.
49. Reyes-Fermin L.M., Gonzalez-Reyes S., Tarco-Alvarez N.G., Hernandez-Nava M., Orozco-Ibarra M., Pedraza-Chaverri J. Neuroprotective effect of alpha-mangostin and curcumin against iodoacetate-induced cell death. Nutr. Neurosci. 2012, 15:34-41.
50. Sanchez-Perez Y., Morales-Barcenas R., Garcia-Cuellar C.M., Lopez-Marure R., Calderon-Oliver M., Pedraza-Chaverri J., Chirino Y.I. The alpha-mangostin prevention on cisplatin-induced apoptotic death in LLC-PK1 cells is associated to an inhibition of ROS production and p53 induction. Chem. Biol. Interact. 2010, 188:144-150.
51. Pedraza-Chaverri J., Reyes-Fermin L.M., Nolasco-Amaya E.G., Orozco-Ibarra M., Medina-Campos O.N., Gonzalez-Cuahutencos O., Rivero-Cruz I., Mata R. ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp. Toxicol. Pathol.: Official J. Ges. Toxikol. Pathol. 2009, 61:491-501.